Indications
Therapeutic Class
Pharmacology
Dosage
The usual dosages for adults are as follows:
- For depression: 10 mg to 150 mg daily. Severe cases may need even higher doses.
- For obsessions and phobias: 10 mg to 150 mg daily.
- For cataplexy: 10 mg to 75 mg daily.
The elderly: Elderly patients often need a lower dose because they are more likely to experience side effects.
Administration
Interaction
Contraindications
- Known hypersensitivity to clomipramine and any of the excipients in the tablets.
- Cross-hypersensitivity to tricyclic antidepressants of the dibenzazepine group.
- Concomitant use with a monoamine oxidase (MAO) inhibitor, or within 14 days before or after treatment with an irreversible MAO inhibitor, or within 14 days before moclobemide, a reversible MAO inhibitor.
- Acute and recovery stages of myocardial infarction.
- Congenital long QT syndrome.
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Check with your doctor or pharmacist before taking your medicine if:
- you have epilepsy (fits)
- you have an overactive thyroid gland
- you have a tumour (cancer) of the adrenal gland (such as phaeochromocytoma or neuroblastoma)
- you have low blood pressure
- you wear contact lenses
- you have had severe constipation for a long time
- you find yourself thinking about suicide
- you have had a head injury and suffered brain damage
- you are going to have ECT (electroconvulsive therapy)
- you have an irregular heart beat or other problems with your heart
- you have been diagnosed as having a low level of potassium in your blood (hypokalemia)
- you have schizophrenia or any other mental disorder
- you are elderly
- you have glaucoma(increased pressure in the eye)
- you have liver or kidney disease
- you have any blood disorder
- you have difficulties in passing urine (e.g. due to diseases of the prostate)
Use in Special Populations
Older people: Elderly patients generally need lower doses than young and middle-aged patients. Side effects are more likely to occur in older patients.
Use in Children and Adolescents (<18 years): The safety and efficacy of clomipramine for the treatment of depression or other psychiatric disorders in children and adolescents aged less than 18 years has not been satisfactorily established. Clomipramine should not be used in this age group for the treatment of depression or other psychiatric disorders
Reviews
There are no reviews yet.